Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

Divided or Single Exposure (DOSE) Study

NCT05459402 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)

NCT03638869 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults

NCT01046539 ·Status: COMPLETED ·Phase: PHASE1

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

NCT00504413 ·Status: UNKNOWN ·Phase: PHASE1

Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.

NCT01793480 ·Status: COMPLETED ·Phase: PHASE3

Low-dose Buprenorphine Initiation for Opioid Use Disorder

NCT05450718 ·Status: RECRUITING ·Phase: PHASE4

Methadone/Buprenorphine Cross-Over Study - 4

NCT00000208 ·Status: COMPLETED ·Phase: PHASE2

A Study of Oral Ibogaine in Opioid Withdrawal

NCT05029401 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole

NCT01259115 ·Status: COMPLETED ·Phase: PHASE1

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

NCT00469404 ·Status: TERMINATED ·Phase: PHASE1

Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine

NCT01367808 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

NCT00463047 ·Status: COMPLETED ·Phase: PHASE3

Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk

NCT05976984 ·Status: COMPLETED

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

NCT01841931 ·Status: TERMINATED ·Phase: PHASE4

Extended-release Pharmacotherapy for Opioid Use Disorder

NCT05164549 ·Status: COMPLETED ·Phase: PHASE3

Morphine Slow-release Capsules in Substitution Therapy

NCT01079117 ·Status: COMPLETED ·Phase: PHASE3

ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD

NCT01381107 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Alternate-Day Buprenorphine Administration. Phase II - 4

NCT00000222 ·Status: COMPLETED ·Phase: PHASE1

Study of D-Methadone in Patients With Chronic Pain

NCT00588640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Alternate-Day Buprenorphine Administration. Phase I - 3

NCT00000221 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film

NCT01871285 ·Status: COMPLETED ·Phase: PHASE2

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

NCT07314346 ·Status: RECRUITING ·Phase: PHASE1

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

NCT00813488 ·Status: COMPLETED ·Phase: PHASE3

Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain

NCT00356083 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

NCT04447287 ·Status: COMPLETED ·Phase: PHASE1